Offer - Urjas Oil for just ₹ 1 X
Milza 25 Capsule is a commercial drug that is prescribed in the form of Capsule. It is typically used for the treatment of Fibromyalgia. Milza 25 Capsule also has some secondary and off-label uses. These are listed below.
The correct dosage of Milza 25 Capsule depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Milza 25 Capsule have been listed ahead. Usually, these side effects of Milza 25 Capsule go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Milza 25 Capsule's effect during pregnancy is Moderate and Moderate while nursing. Warnings related to Milza 25 Capsule's effects on the liver, heart and kidney, if any, have been listed below.
Milza 25 Capsule is contraindicated in people with pre-existing medical conditions like Kidney Disease, Liver Disease, Depression as it can result in adverse effects. Some other conditions that can be affected by Milza 25 Capsule are listed in the contraindications section below.
Drug reaction of Milza 25 Capsule with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Milza 25 Capsule is considered not safe while driving, and is not addictive.
Milza 25 Capsule is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Milza 25 Capsule safe for pregnant women?
Milza may have some side effects during pregnancy. Pregnant women should discontinue the use of Milza, and talk to their doctor, if they notice any discomfort.
Is the use of Milza 25 Capsule safe during breastfeeding?
Breastfeeding women may feel side effects of Milza. If you see any side effects, stop taking Milza immediately and talk to your doctor. Take Milza again, only after your doctor's advice.
What is the effect of Milza 25 Capsule on the Kidneys?
Kidney can be affected by Milza. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Milza 25 Capsule on the Liver?
There may be an adverse effect on the liver after taking Milza. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Milza 25 Capsule on the Heart?
The heart can be affected by Milza. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Milza 25 Capsule unless your doctor advises you to do so -
Is this Milza 25 Capsule habit forming or addictive?
Forming a habit of Milza 25 Capsule has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Milza 25 Capsule, you should not drive or work on any heavy machine, as Milza 25 Capsule can make you drowsy.
Is it safe?
Milza 25 Capsule is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Milza 25 Capsule cannot treat any kind of mental disorder.
Interaction between Food and Milza 25 Capsule
Information is not available on the interaction of any foods with Milza 25 Capsule, due to a lack of research on this.
Interaction between Alcohol and Milza 25 Capsule
Taking alcohol with Milza 25 Capsule can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 860-861
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Savella® (milnacipran hydrochloride)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Joncia® (milnacipran hydrochloride)